Clinical Study
Dermoscopic Follow-Up of the Skin towards Acute Graft-versus-Host-Disease in Patients after Allogeneic Hematopoietic Stem Cell Transplantation
Table 1
Patient and donor characteristics.
| Median patient age (range) | 42 (22–59) years | Median donor age (range) | 38 (20–63) years | Median time from diagnosis to transplantation | 0.84 (0.43–5.7) years | Donor/patient sex, (%) | | Male/male | 2 (15%) | Female/male | 5 (38%) | Male/female | 2 (15%) | Female/female | 4 (31%) | Donor/patient CMV status, (%) | | Negative/negative | 0 | Negative/positive | 1 (8%) | Positive/negative | 2 (15%) | Positive/positive | 10 (77%) | Donor, (%) | | HLA-identical sibling | 9 (69%) | Matched unrelated | 4 (31%) | Diagnosis, | | AML | 3 | ALL | 2 | CML | 1 | SAA | 1 | OMF | 1 | MDS/MPS | 1 | Sézary syndrome | 1 | Lymphomas | 2 | CAEBV | 1 |
|
|